{"transactions":[{"id":712501,"issuer":{"id":5634,"kind":"organization","name":"Larimar Therapeutics, Inc."},"owners":[{"id":31399,"kind":"person","name":"Hamilton Thomas Edward","position":1,"cik":"0001769848","reported_name":"Hamilton Thomas Edward","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-07-08T20:05:03.000Z","date":"2026-07-06","kind":"purchase","planned":false,"acquired":true,"shares":50000,"price":3.3378,"value":166890.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.33 to $3.35, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein."}],"balance_after":714798,"source":{"system":"sec-edgar","filing":"0001193125-26-298523","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1374690/000119312526298523/ownership.xml","form_type":"4"}},{"id":740437,"issuer":{"id":3308,"kind":"organization","name":"ANNALY CAPITAL MANAGEMENT INC"},"owners":[{"id":31399,"kind":"person","name":"Hamilton Thomas Edward","position":1,"cik":"0001769848","reported_name":"Hamilton Thomas Edward","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Stock Units","published_at":"2026-06-12T20:04:10.000Z","date":"2026-06-10","kind":"grant","planned":false,"acquired":true,"shares":8641,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Deferred Stock Units (\"DSUs\") convert to shares of Common Stock on a one-for-one basis one year after the date of grant unless the director elects to defer the settlement of the DSUs until after a termination of service pursuant to the Annaly Capital Management, Inc. 2020 Equity Incentive Plan. The reporting person has elected such deferred settlement for all DSUs reported above."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Deferred Stock Units (\"DSUs\") convert to shares of Common Stock on a one-for-one basis one year after the date of grant unless the director elects to defer the settlement of the DSUs until after a termination of service pursuant to the Annaly Capital Management, Inc. 2020 Equity Incentive Plan. The reporting person has elected such deferred settlement for all DSUs reported above."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Deferred Stock Units (\"DSUs\") convert to shares of Common Stock on a one-for-one basis one year after the date of grant unless the director elects to defer the settlement of the DSUs until after a termination of service pursuant to the Annaly Capital Management, Inc. 2020 Equity Incentive Plan. The reporting person has elected such deferred settlement for all DSUs reported above."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Reflects the aggregate amount of DSUs granted during the tenure of the respective director net of any conversions."}],"balance_after":53884,"derivative":{"underlying":"Common Stock","underlying_shares":8641},"source":{"system":"sec-edgar","filing":"0001769848-26-000002","document":"wk-form4_1781294647.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1043219/000176984826000002/wk-form4_1781294647.xml","form_type":"4"}},{"id":769679,"issuer":{"id":5634,"kind":"organization","name":"Larimar Therapeutics, Inc."},"owners":[{"id":31399,"kind":"person","name":"Hamilton Thomas Edward","position":1,"cik":"0001769848","reported_name":"Hamilton Thomas Edward","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-05-20T20:21:39.000Z","date":"2026-05-19","kind":"grant","planned":false,"acquired":true,"shares":55150,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest on the earlier of (a) May 19, 2027 or (b) the date of the Company's next annual meeting of stockholders, in each case subject to the Reporting Person's continued service on the Board of Directors of the Company."}],"balance_after":55150,"derivative":{"exercise_price":3.33,"expiration_date":"2036-05-19","underlying":"Common Stock","underlying_shares":55150},"source":{"system":"sec-edgar","filing":"0001193125-26-232644","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1374690/000119312526232644/ownership.xml","form_type":"4"}},{"id":873676,"issuer":{"id":5634,"kind":"organization","name":"Larimar Therapeutics, Inc."},"owners":[{"id":31399,"kind":"person","name":"Hamilton Thomas Edward","position":1,"cik":"0001769848","reported_name":"Hamilton Thomas Edward","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-03-02T21:30:41.000Z","date":"2026-02-27","kind":"purchase","planned":false,"acquired":true,"shares":100000,"price":5,"value":500000.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock purchased in the underwritten offering of Larimar Therapeutics, Inc. at the offering price, which closed on February 27, 2026."}],"balance_after":664798,"source":{"system":"sec-edgar","filing":"0001193125-26-085515","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1374690/000119312526085515/ownership.xml","form_type":"4"}},{"id":1147920,"issuer":{"id":3308,"kind":"organization","name":"ANNALY CAPITAL MANAGEMENT INC"},"owners":[{"id":31399,"kind":"person","name":"Hamilton Thomas Edward","position":1,"cik":"0001769848","reported_name":"Hamilton Thomas Edward","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Stock Units","published_at":"2025-05-15T20:16:42.000Z","date":"2025-05-14","kind":"grant","planned":false,"acquired":true,"shares":8961,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Deferred Stock Units (\"DSUs\") convert to shares of Common Stock on a one-for-one basis one year after the date of grant unless the director elects to defer the settlement of the DSUs until after a termination of service pursuant to the Annaly Capital Management, Inc. 2010 Equity Incentive Plan or the Annaly Capital Management, Inc. 2020 Equity Incentive Plan, as applicable. The reporting person has elected such deferred settlement for all DSUs reported above."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Deferred Stock Units (\"DSUs\") convert to shares of Common Stock on a one-for-one basis one year after the date of grant unless the director elects to defer the settlement of the DSUs until after a termination of service pursuant to the Annaly Capital Management, Inc. 2010 Equity Incentive Plan or the Annaly Capital Management, Inc. 2020 Equity Incentive Plan, as applicable. The reporting person has elected such deferred settlement for all DSUs reported above."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Deferred Stock Units (\"DSUs\") convert to shares of Common Stock on a one-for-one basis one year after the date of grant unless the director elects to defer the settlement of the DSUs until after a termination of service pursuant to the Annaly Capital Management, Inc. 2010 Equity Incentive Plan or the Annaly Capital Management, Inc. 2020 Equity Incentive Plan, as applicable. The reporting person has elected such deferred settlement for all DSUs reported above."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Reflects the aggregate amount of DSUs granted during the tenure of the respective director net of any conversions."}],"balance_after":45243,"derivative":{"underlying":"Common Stock","underlying_shares":8961},"source":{"system":"sec-edgar","filing":"0001628280-25-025929","document":"wk-form4_1747340192.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1043219/000162828025025929/wk-form4_1747340192.xml","form_type":"4"}},{"id":1148913,"issuer":{"id":5634,"kind":"organization","name":"Larimar Therapeutics, Inc."},"owners":[{"id":31399,"kind":"person","name":"Hamilton Thomas Edward","position":1,"cik":"0001769848","reported_name":"Hamilton Thomas Edward","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-05-14T20:33:13.000Z","date":"2025-05-13","kind":"grant","planned":false,"acquired":true,"shares":19000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest on the earlier of (a) May 13, 2026 or (b) the date of the Company's next annual meeting of stockholders, in each case subject to the Reporting Person's continued service on the Board of Directors of the Company."}],"balance_after":19000,"derivative":{"exercise_price":1.875,"expiration_date":"2035-05-13","underlying":"Common Stock","underlying_shares":19000},"source":{"system":"sec-edgar","filing":"0001062993-25-009378","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1374690/000106299325009378/form4.xml","form_type":"4"}},{"id":1496375,"issuer":{"id":5634,"kind":"organization","name":"Larimar Therapeutics, Inc."},"owners":[{"id":31399,"kind":"person","name":"Hamilton Thomas Edward","position":1,"cik":"0001769848","reported_name":"Hamilton Thomas Edward","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-05-31T20:56:58.000Z","date":"2024-05-29","kind":"grant","planned":false,"acquired":true,"shares":19000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest on the earlier of (a) May 29, 2025 or (b) the date of the Company's next annual meeting of stockholders, in each case subject to the Reporting Person's continued service on the Board of Directors of the Company."}],"balance_after":19000,"derivative":{"exercise_price":7.07,"expiration_date":"2034-05-29","underlying":"Common Stock","underlying_shares":19000},"source":{"system":"sec-edgar","filing":"0001062993-24-011568","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1374690/000106299324011568/form4.xml","form_type":"4"}},{"id":1496374,"issuer":{"id":5634,"kind":"organization","name":"Larimar Therapeutics, Inc."},"owners":[{"id":31399,"kind":"person","name":"Hamilton Thomas Edward","position":1,"cik":"0001769848","reported_name":"Hamilton Thomas Edward","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-31T20:56:58.000Z","date":"2024-02-16","kind":"purchase","planned":false,"acquired":true,"shares":57208,"price":8.74,"value":499997.92,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock purchased in the underwritten offering of Larimar Therapeutics, Inc. (the \"Company\") at the offering price, which closed on February 16, 2024."}],"balance_after":564798,"source":{"system":"sec-edgar","filing":"0001062993-24-011568","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1374690/000106299324011568/form4.xml","form_type":"4"}},{"id":1512207,"issuer":{"id":3308,"kind":"organization","name":"ANNALY CAPITAL MANAGEMENT INC"},"owners":[{"id":31399,"kind":"person","name":"Hamilton Thomas Edward","position":1,"cik":"0001769848","reported_name":"Hamilton Thomas Edward","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Stock Units","published_at":"2024-05-17T21:44:24.000Z","date":"2024-05-15","kind":"grant","planned":false,"acquired":true,"shares":8583,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Deferred Stock Units (\"DSUs\") convert to shares of Common Stock on a one-for-one basis one year after the date of grant unless the director elects to defer the settlement of the DSUs until after a termination of service pursuant to the Annaly Capital Management, Inc. 2010 Equity Incentive Plan or the Annaly Capital Management, Inc. 2020 Equity Incentive Plan, as applicable. The reporting person has elected such deferred settlement for all DSUs reported above."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Deferred Stock Units (\"DSUs\") convert to shares of Common Stock on a one-for-one basis one year after the date of grant unless the director elects to defer the settlement of the DSUs until after a termination of service pursuant to the Annaly Capital Management, Inc. 2010 Equity Incentive Plan or the Annaly Capital Management, Inc. 2020 Equity Incentive Plan, as applicable. The reporting person has elected such deferred settlement for all DSUs reported above."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Deferred Stock Units (\"DSUs\") convert to shares of Common Stock on a one-for-one basis one year after the date of grant unless the director elects to defer the settlement of the DSUs until after a termination of service pursuant to the Annaly Capital Management, Inc. 2010 Equity Incentive Plan or the Annaly Capital Management, Inc. 2020 Equity Incentive Plan, as applicable. The reporting person has elected such deferred settlement for all DSUs reported above."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Reflects the aggregate amount of DSUs granted during the tenure of the respective director net of any conversions."}],"balance_after":36282,"derivative":{"underlying":"Common Stock","underlying_shares":8583},"source":{"system":"sec-edgar","filing":"0001628280-24-024178","document":"wk-form4_1715982252.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1043219/000162828024024178/wk-form4_1715982252.xml","form_type":"4"}},{"id":1885404,"issuer":{"id":3308,"kind":"organization","name":"ANNALY CAPITAL MANAGEMENT INC"},"owners":[{"id":31399,"kind":"person","name":"Hamilton Thomas Edward","position":1,"cik":"0001769848","reported_name":"Hamilton Thomas Edward","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Stock Units","published_at":"2023-05-19T20:53:08.000Z","date":"2023-05-17","kind":"grant","planned":false,"acquired":true,"shares":8167,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Deferred Stock Units (\"DSUs\") convert to shares of Common Stock on a one-for-one basis one year after the date of grant unless the director elects to defer the settlement of the DSUs until after a termination of service pursuant to the Annaly Capital Management, Inc. 2010 Equity Incentive Plan or the Annaly Capital Management, Inc. 2020 Equity Incentive Plan as applicable. The reporting person has elected such deferred settlement for all DSUs reported above."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Deferred Stock Units (\"DSUs\") convert to shares of Common Stock on a one-for-one basis one year after the date of grant unless the director elects to defer the settlement of the DSUs until after a termination of service pursuant to the Annaly Capital Management, Inc. 2010 Equity Incentive Plan or the Annaly Capital Management, Inc. 2020 Equity Incentive Plan as applicable. The reporting person has elected such deferred settlement for all DSUs reported above."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Deferred Stock Units (\"DSUs\") convert to shares of Common Stock on a one-for-one basis one year after the date of grant unless the director elects to defer the settlement of the DSUs until after a termination of service pursuant to the Annaly Capital Management, Inc. 2010 Equity Incentive Plan or the Annaly Capital Management, Inc. 2020 Equity Incentive Plan as applicable. The reporting person has elected such deferred settlement for all DSUs reported above."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Reflects the aggregate amount of DSUs granted during the tenure of the respective director net of any conversions."}],"balance_after":27698,"derivative":{"underlying":"Common Stock","underlying_shares":8167},"source":{"system":"sec-edgar","filing":"0001628280-23-019100","document":"wf-form4_168452956622468.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1043219/000162828023019100/wf-form4_168452956622468.xml","form_type":"4"}},{"id":1896473,"issuer":{"id":5634,"kind":"organization","name":"Larimar Therapeutics, Inc."},"owners":[{"id":31399,"kind":"person","name":"Hamilton Thomas Edward","position":1,"cik":"0001769848","reported_name":"Hamilton Thomas Edward","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-05-11T20:29:31.000Z","date":"2023-05-09","kind":"grant","planned":false,"acquired":true,"shares":8300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest on the earlier of (a) May 9, 2024 or (b) the date of the Company's next annual meeting of stockholders, in each case subject to the Reporting Person's continued service on the Board of Directors of the Company."}],"balance_after":8300,"derivative":{"exercise_price":5.09,"expiration_date":"2033-05-09","underlying":"Common Stock","underlying_shares":8300},"source":{"system":"sec-edgar","filing":"0001062993-23-010807","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1374690/000106299323010807/form4.xml","form_type":"4"}},{"id":2153908,"issuer":{"id":5634,"kind":"organization","name":"Larimar Therapeutics, Inc."},"owners":[{"id":31399,"kind":"person","name":"Hamilton Thomas Edward","position":1,"cik":"0001769848","reported_name":"Hamilton Thomas Edward","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-09-20T10:54:26.000Z","date":"2022-09-16","kind":"purchase","acquired":true,"shares":317460,"price":3.15,"value":999999.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock purchased in the underwritten offering of Larimar Therapeutics, Inc. at the offering price, which closed on September 16, 2022."}],"balance_after":507590,"source":{"system":"sec-edgar","filing":"0001062993-22-019753","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1374690/000106299322019753/form4.xml","form_type":"4"}},{"id":2262317,"issuer":{"id":3308,"kind":"organization","name":"ANNALY CAPITAL MANAGEMENT INC"},"owners":[{"id":31399,"kind":"person","name":"Hamilton Thomas Edward","position":1,"cik":"0001769848","reported_name":"Hamilton Thomas Edward","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Stock Units","published_at":"2022-05-20T21:04:17.000Z","date":"2022-05-18","kind":"grant","acquired":true,"shares":24372,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Deferred Stock Units (\"DSUs\") convert to shares of Common Stock on a one-for-one basis one year after the date of grant unless the director elects to defer the settlement of the DSUs until after a termination of service pursuant to the Annaly Capital Management, Inc. 2010 Equity Incentive Plan or the Annaly Capital Management, Inc. 2020 Equity Incentive Plan as applicable. The reporting person has elected such deferred settlement for all DSUs reported above."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Deferred Stock Units (\"DSUs\") convert to shares of Common Stock on a one-for-one basis one year after the date of grant unless the director elects to defer the settlement of the DSUs until after a termination of service pursuant to the Annaly Capital Management, Inc. 2010 Equity Incentive Plan or the Annaly Capital Management, Inc. 2020 Equity Incentive Plan as applicable. The reporting person has elected such deferred settlement for all DSUs reported above."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Deferred Stock Units (\"DSUs\") convert to shares of Common Stock on a one-for-one basis one year after the date of grant unless the director elects to defer the settlement of the DSUs until after a termination of service pursuant to the Annaly Capital Management, Inc. 2010 Equity Incentive Plan or the Annaly Capital Management, Inc. 2020 Equity Incentive Plan as applicable. The reporting person has elected such deferred settlement for all DSUs reported above."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Reflects the aggregate amount of DSUs granted during the tenure of the respective director net of any conversions."}],"balance_after":78124,"derivative":{"underlying":"Common Stock","underlying_shares":24372},"source":{"system":"sec-edgar","filing":"0001628280-22-015065","document":"wf-form4_165308061680864.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1043219/000162828022015065/wf-form4_165308061680864.xml","form_type":"4"}},{"id":2273184,"issuer":{"id":5634,"kind":"organization","name":"Larimar Therapeutics, Inc."},"owners":[{"id":31399,"kind":"person","name":"Hamilton Thomas Edward","position":1,"cik":"0001769848","reported_name":"Hamilton Thomas Edward","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-05-13T00:27:31.000Z","date":"2022-05-10","kind":"grant","acquired":true,"shares":8300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest on the earlier of (a) May 10, 2023 or (b) the date of the Company's next annual meeting of stockholders, in each case subject to the Reporting Person's continued service on the Board of Directors of the Company."}],"balance_after":8300,"derivative":{"exercise_price":2.92,"expiration_date":"2032-05-10","underlying":"Common Stock","underlying_shares":8300},"source":{"system":"sec-edgar","filing":"0001062993-22-012305","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1374690/000106299322012305/form4.xml","form_type":"4"}},{"id":2643846,"issuer":{"id":5634,"kind":"organization","name":"Larimar Therapeutics, Inc."},"owners":[{"id":31399,"kind":"person","name":"Hamilton Thomas Edward","position":1,"cik":"0001769848","reported_name":"Hamilton Thomas Edward","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-07-02T20:08:42.000Z","date":"2021-06-30","kind":"purchase","acquired":true,"shares":56710,"price":8.75,"value":496212.5,"ownership":{"direct":true},"balance_after":190130,"source":{"system":"sec-edgar","filing":"0001192482-21-000601","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1374690/000119248221000601/edgar.xml","form_type":"4"}},{"id":2701393,"issuer":{"id":3308,"kind":"organization","name":"ANNALY CAPITAL MANAGEMENT INC"},"owners":[{"id":31399,"kind":"person","name":"Hamilton Thomas Edward","position":1,"cik":"0001769848","reported_name":"Hamilton Thomas Edward","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Stock Units","published_at":"2021-05-21T22:25:09.000Z","date":"2021-05-19","kind":"grant","acquired":true,"shares":15609,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Deferred Stock Units (\"DSUs\") convert to shares of Common Stock on a one-for-one basis one year after the date of grant unless the director elects to defer the settlement of the DSUs until after a termination of service pursuant to the Annaly Capital Management, Inc. 2010 Equity Incentive Plan or the Annaly Capital Management, Inc. 2020 Equity Incentive Plan as applicable. The reporting person has elected such deferred settlement for all DSUs reported above."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Deferred Stock Units (\"DSUs\") convert to shares of Common Stock on a one-for-one basis one year after the date of grant unless the director elects to defer the settlement of the DSUs until after a termination of service pursuant to the Annaly Capital Management, Inc. 2010 Equity Incentive Plan or the Annaly Capital Management, Inc. 2020 Equity Incentive Plan as applicable. The reporting person has elected such deferred settlement for all DSUs reported above."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Deferred Stock Units (\"DSUs\") convert to shares of Common Stock on a one-for-one basis one year after the date of grant unless the director elects to defer the settlement of the DSUs until after a termination of service pursuant to the Annaly Capital Management, Inc. 2010 Equity Incentive Plan or the Annaly Capital Management, Inc. 2020 Equity Incentive Plan as applicable. The reporting person has elected such deferred settlement for all DSUs reported above."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Reflects the aggregate amount of DSUs granted during the tenure of the respective director net of any conversions."}],"balance_after":53752,"derivative":{"underlying":"Common Stock","underlying_shares":15609},"source":{"system":"sec-edgar","filing":"0001628280-21-010935","document":"wf-form4_162163589491694.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1043219/000162828021010935/wf-form4_162163589491694.xml","form_type":"4"}},{"id":2709996,"issuer":{"id":5634,"kind":"organization","name":"Larimar Therapeutics, Inc."},"owners":[{"id":31399,"kind":"person","name":"Hamilton Thomas Edward","position":1,"cik":"0001769848","reported_name":"Hamilton Thomas Edward","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-05-17T20:59:43.000Z","date":"2021-05-12","kind":"grant","acquired":true,"shares":8300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Option vests on the earlier of (a) May 12, 2022 or (b) the date of the Company's next annual meeting of stockholders, in each case subject to the Reporting Person's continued service on the Board of Directors of the Company."}],"balance_after":8300,"derivative":{"exercise_price":10.34,"expiration_date":"2031-05-12","underlying":"Common Stock","underlying_shares":8300},"source":{"system":"sec-edgar","filing":"0001192482-21-000438","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1374690/000119248221000438/edgar.xml","form_type":"4"}},{"id":2730953,"issuer":{"id":3308,"kind":"organization","name":"ANNALY CAPITAL MANAGEMENT INC"},"owners":[{"id":31399,"kind":"person","name":"Hamilton Thomas Edward","position":1,"cik":"0001769848","reported_name":"Hamilton Thomas Edward","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-04T20:31:53.000Z","date":"2021-05-03","kind":"sale","acquired":false,"shares":80000,"price":9.1804,"value":734432.0,"ownership":{"direct":false,"nature":"2012 Hamilton Family Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale was made in connection with the reporting person's estate planning"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $9.18 to $9.185. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected"}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001628280-21-008886","document":"wf-form4_162016025387022.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1043219/000162828021008886/wf-form4_162016025387022.xml","form_type":"4"}},{"id":3019684,"issuer":{"id":5634,"kind":"organization","name":"Larimar Therapeutics, Inc."},"owners":[{"id":31399,"kind":"person","name":"Hamilton Thomas Edward","position":1,"cik":"0001769848","reported_name":"Hamilton Thomas Edward","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-09-30T18:14:59.000Z","date":"2020-09-29","kind":"grant","acquired":true,"shares":16600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Option was granted on July 16, 2020 subject to stockholder approval, which was obtained at the Company's special meeting of stockholders on September 29, 2020. The vesting commencement date for the option is July 16, 2020, and the option vests in equal monthly installments over 36 months, subject to the Reporting Person's continued service with the Issuer through each applicable vesting date."}],"balance_after":16600,"derivative":{"exercise_price":11.9,"expiration_date":"2030-07-16","underlying":"Common Stock","underlying_shares":16600},"source":{"system":"sec-edgar","filing":"0001192482-20-000751","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1374690/000119248220000751/edgar.xml","form_type":"4"}},{"id":3096387,"issuer":{"id":5634,"kind":"organization","name":"Larimar Therapeutics, Inc."},"owners":[{"id":31399,"kind":"person","name":"Hamilton Thomas Edward","position":1,"cik":"0001769848","reported_name":"Hamilton Thomas Edward","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-30T21:02:24.000Z","date":"2020-06-26","kind":"other","acquired":true,"shares":159433,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"FA Life Sciences, Inc."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Pro rata distribution from Holdings to its members, for no consideration."}],"balance_after":292853,"source":{"system":"sec-edgar","filing":"0001192482-20-000588","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1374690/000119248220000588/edgar.xml","form_type":"4"}},{"id":3096386,"issuer":{"id":5634,"kind":"organization","name":"Larimar Therapeutics, Inc."},"owners":[{"id":31399,"kind":"person","name":"Hamilton Thomas Edward","position":1,"cik":"0001769848","reported_name":"Hamilton Thomas Edward","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-30T21:02:24.000Z","date":"2020-06-26","kind":"other","acquired":true,"shares":133420,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pro rata distribution from Chondrial Therapeutics Holdings, LLC (\"Holdings\") to its members, for no consideration.  The reporting person is a member of the board of managers of Holdings."}],"balance_after":133420,"source":{"system":"sec-edgar","filing":"0001192482-20-000588","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1374690/000119248220000588/edgar.xml","form_type":"4"}},{"id":3137721,"issuer":{"id":3308,"kind":"organization","name":"ANNALY CAPITAL MANAGEMENT INC"},"owners":[{"id":31399,"kind":"person","name":"Hamilton Thomas Edward","position":1,"cik":"0001769848","reported_name":"Hamilton Thomas Edward","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Stock Units","published_at":"2020-05-22T17:54:52.000Z","date":"2020-05-20","kind":"grant","acquired":true,"shares":22551,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Deferred Stock Units (\"DSUs\") convert to shares of Common Stock on a one-for-one basis one year after the date of grant unless the director elects to defer the settlement of the DSUs until after a termination of service pursuant to the Annaly Capital Management, Inc. 2010 Equity Incentive Plan. The reporting person has elected such deferred settlement for all DSUs reported above."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Deferred Stock Units (\"DSUs\") convert to shares of Common Stock on a one-for-one basis one year after the date of grant unless the director elects to defer the settlement of the DSUs until after a termination of service pursuant to the Annaly Capital Management, Inc. 2010 Equity Incentive Plan. The reporting person has elected such deferred settlement for all DSUs reported above."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Deferred Stock Units (\"DSUs\") convert to shares of Common Stock on a one-for-one basis one year after the date of grant unless the director elects to defer the settlement of the DSUs until after a termination of service pursuant to the Annaly Capital Management, Inc. 2010 Equity Incentive Plan. The reporting person has elected such deferred settlement for all DSUs reported above."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Reflects the aggregate amount of DSUs granted during the tenure of the respective director net of any conversions."}],"balance_after":38143,"derivative":{"underlying":"Common Stock","underlying_shares":22551},"source":{"system":"sec-edgar","filing":"0001628280-20-008269","document":"wf-form4_159017007389681.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1043219/000162828020008269/wf-form4_159017007389681.xml","form_type":"4"}},{"id":3147616,"issuer":{"id":3308,"kind":"organization","name":"ANNALY CAPITAL MANAGEMENT INC"},"owners":[{"id":31399,"kind":"person","name":"Hamilton Thomas Edward","position":1,"cik":"0001769848","reported_name":"Hamilton Thomas Edward","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-15T20:58:24.000Z","date":"2020-05-15","kind":"purchase","acquired":true,"shares":200000,"price":5.9646,"value":1192920.0,"ownership":{"direct":false,"nature":"Cure FA Foundation, Inc."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported above reflects the weighted average purchase price. The highest price at which the shares were purchased was $5.97 and the lowest price at which the shares were purchased was $5.945. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote in this Form 4."}],"balance_after":330000,"source":{"system":"sec-edgar","filing":"0001628280-20-007917","document":"wf-form4_158957628368975.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1043219/000162828020007917/wf-form4_158957628368975.xml","form_type":"4"}},{"id":3512163,"issuer":{"id":3308,"kind":"organization","name":"ANNALY CAPITAL MANAGEMENT INC"},"owners":[{"id":31399,"kind":"person","name":"Hamilton Thomas Edward","position":1,"cik":"0001769848","reported_name":"Hamilton Thomas Edward","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Stock Units","published_at":"2019-05-24T18:12:06.000Z","date":"2019-05-22","kind":"grant","acquired":true,"shares":15592,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Deferred Stock Units (\"DSUs\") convert to shares of Common Stock on a one-for-one basis one year after the date of grant unless the director elects to defer the settlement of the DSUs until after a termination of service pursuant to the Annaly Capital Management, Inc. 2010 Equity Incentive Plan. The reporting person has elected such deferred settlement for all DSUs reported above."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Deferred Stock Units (\"DSUs\") convert to shares of Common Stock on a one-for-one basis one year after the date of grant unless the director elects to defer the settlement of the DSUs until after a termination of service pursuant to the Annaly Capital Management, Inc. 2010 Equity Incentive Plan. The reporting person has elected such deferred settlement for all DSUs reported above."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Deferred Stock Units (\"DSUs\") convert to shares of Common Stock on a one-for-one basis one year after the date of grant unless the director elects to defer the settlement of the DSUs until after a termination of service pursuant to the Annaly Capital Management, Inc. 2010 Equity Incentive Plan. The reporting person has elected such deferred settlement for all DSUs reported above."}],"balance_after":15592,"derivative":{"underlying":"Common Stock","underlying_shares":15592},"source":{"system":"sec-edgar","filing":"0001628280-19-007193","document":"wf-form4_155872151122430.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1043219/000162828019007193/wf-form4_155872151122430.xml","form_type":"4"}},{"id":3518923,"issuer":{"id":3308,"kind":"organization","name":"ANNALY CAPITAL MANAGEMENT INC"},"owners":[{"id":31399,"kind":"person","name":"Hamilton Thomas Edward","position":1,"cik":"0001769848","reported_name":"Hamilton Thomas Edward","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-05-20T11:08:06.000Z","date":"2019-05-17","kind":"purchase","acquired":true,"shares":30000,"price":9.47,"value":284100.0,"ownership":{"direct":false,"nature":"2012 Hamilton Family Trust"},"balance_after":80000,"source":{"system":"sec-edgar","filing":"0001628280-19-007010","document":"wf-form4_155835047039247.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1043219/000162828019007010/wf-form4_155835047039247.xml","form_type":"4"}},{"id":3518922,"issuer":{"id":3308,"kind":"organization","name":"ANNALY CAPITAL MANAGEMENT INC"},"owners":[{"id":31399,"kind":"person","name":"Hamilton Thomas Edward","position":1,"cik":"0001769848","reported_name":"Hamilton Thomas Edward","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-05-20T11:08:06.000Z","date":"2019-05-17","kind":"purchase","acquired":true,"shares":30000,"price":9.47,"value":284100.0,"ownership":{"direct":false,"nature":"Cure FA Foundation, Inc."},"balance_after":130000,"source":{"system":"sec-edgar","filing":"0001628280-19-007010","document":"wf-form4_155835047039247.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1043219/000162828019007010/wf-form4_155835047039247.xml","form_type":"4"}},{"id":3518921,"issuer":{"id":3308,"kind":"organization","name":"ANNALY CAPITAL MANAGEMENT INC"},"owners":[{"id":31399,"kind":"person","name":"Hamilton Thomas Edward","position":1,"cik":"0001769848","reported_name":"Hamilton Thomas Edward","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-05-20T11:08:06.000Z","date":"2019-05-17","kind":"purchase","acquired":true,"shares":30000,"price":9.4698,"value":284094.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported above reflects the weighted average purchase price. The highest price at which the shares were purchased was $9.470 and the lowest price at which the shares were purchased was $9.465. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote in this Form 4."}],"balance_after":130000,"source":{"system":"sec-edgar","filing":"0001628280-19-007010","document":"wf-form4_155835047039247.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1043219/000162828019007010/wf-form4_155835047039247.xml","form_type":"4"}}]}